Regeneron and Trump Strike a Deal: What It Means for Drug Prices In US
Published on: April 24, 2026, 2:25 a.m. | Source: Times Now
Regeneron struck a drug pricing deal with the Trump administration on Thursday, agreeing to lower costs for some American patients as part of the president's "most favored nation" push. The agreement, which shields Regeneron from pharmaceutical tariffs for three years, makes it the 17th drugmaker to reach such a deal with the White House. , US News, Times Now
